![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 11
Zeitschriftenartikel
Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian und Trarbach, Tanja
(2022):
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
In: Journal of Clinical Oncology, Bd. 40, Nr. 1: S. 72-82
Thomssen, Christoph; Lueftner, Diana; Untch, Michael; Haidinger, Renate; Würstlein, Rachel; Harbeck, Nadia; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Fasching, Peter A.; Foerster, Frank; Kurbacher, Christian M.; Lueck, Hans-Joachim; Marschner, Norbert; Müller, Lothar; Müller, Volkmar; Perlova-Griff, Lidia; Radke, Isabel; Ruckhaeberle, Eugen; Scheffen, Iris; Schumacher-Wulf, Eva; Schwoerer, Moritz; Steinfeld-Birg, Dieter und Ziegler-Loehr, Katja
(2020):
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts.
In: Breast Care, Bd. 15, Nr. 1: S. 82-95
Untch, Michael; Würstlein, Rachel; Lueftner, Diana; Haidinger, Renate; Fasching, Peter A.; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Foerster, Frank; Kurbacher, Christian M.; Lueck, Hans-Joachim; Marschner, Norbert; Müller, Lothar; Müller, Volkmar; Radke, Isabel; Ruckhaeberle, Eugen; Scheffen, Iris; Schumacher-Wulf, Eva; Schwoerer, Moritz; Steinfeld-Birg, Dieter; Ziegler-Loehr, Katja; Thomssen, Christoph und Harbeck, Nadia
(2020):
ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019 Commentary by the German panel of experts on the ABC5 voting results.
In: Geburtshilfe und Frauenheilkunde, Bd. 80, Nr. 06: S. 588-600
Staehler, Michael; Goebell, Peter J.; Müller, Lothar; Emde, Till-Oliver; Wetzel, Natalie; Kruggel, Lisa; Jaenicke, Martina und Marschner, Norbert
(2019):
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
In: International Journal of Cancer, Bd. 146, Nr. 5: S. 1307-1315
Göbell, Peter J.; Stähler, Michael; Müller, Lothar; Nusch, Arnd; Scheffler, Michael; Sauer, Annette; Verschür, Ulla von; Tech, Susanne; Kruggel, Lisa; Jänicke, Martina und Marschner, Norbert
(2018):
Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-Registry.
In: Clinical Genitourinary Cancer, Bd. 16, Nr. 6, E1101-E1115
Thomas, M.; Ponce-Aix, S.; Navarro, A.; Riera-Knorrenschild, J.; Schmidt, M.; Wiegert, E.; Kapp, K.; Wittig, B.; Mauri, C.; Gomez, M. Domine; Kollmeier, J.; Sadjadian, P.; Froehling, K.-P.; Huber, R. M.; Wolf, M.; Pall, Georg; Surmont, Veerle; Bosquee, Leon; Germonpre, Paul; Brückl, Wolfgang; Grah, Christina; Herzmann, Christian; Leistner, Rumo; Meyer, Andreas; Müller, Lothar; Schmalz, Oliver; Scholz, Christian; Schröder, Michael; Serke, Monika; Wesseler, Claas; Brandts, Christian; Kopp, Hans-Georg; Blau, Wolfgang; Griesinger, Frank; Garcia Campelo, Maria Rosario; Garcia Garcia, Yolanda und Trigo Perez, Jose Manuel
(2018):
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study.
In: Annals of Oncology, Bd. 29, Nr. 10: S. 2076-2084
Untch, Michael; Würstlein, Rachel; Marschner, Norbert; Lüftner, Diana; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Haidinger, Renate; Müller, Lothar; Müller, Volkmar; Ruckhäberle, Eugen; Harbeck, Nadia und Thomssen, Christoph
(2018):
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts.
In: Geburtshilfe und Frauenheilkunde, Bd. 78, Nr. 5: S. 469-480
Harbeck, Nadia; Lüftner, Diana; Marschner, Norbert; Untch, Michael; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Haidinger, Renate; Müller, Lothar; Müller, Volkmar; Ruckhäberle, Eugen; Würstlein, Rachel und Thomssen, Christoph
(2018):
ABC4 Consensus: Assessment by a German Group of Experts.
In: Breast Care, Bd. 13, Nr. 1: S. 48-58
Harbeck, Nadia; Saupe, Steffen; Jäger, Elke; Schmidt, Marcus; Kreienberg, Rolf; Müller, Lothar; Otremba, Burkhard Jörg; Waldenmaier, Dirk; Dorn, Julia; Warm, Mathias; Scholz, Michael; Untch, Michael; Wit, Maike de; Barinoff, Jana; Lück, Hans-Joachim; Harter, Philipp; Augustin, Doris; Harnett, Paul; Beckmann, Matthias W. und Al-Batran, Salah-Eddin
(2017):
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
In: Breast Cancer Research and Treatment, Bd. 161, Nr. 1: S. 63-72
[PDF, 711kB]
Thomssen, Christoph; Augustin, Doris; Ettl, Johannes; Haidinger, Renate; Lück, Hans-Joachim; Lueftner, Diana; Marmé, Frederik; Marschner, Norbert; Müller, Lothar; Overkamp, Friedrich; Ruckhäberle, Eugen; Thill, Marc; Untch, Michael; Wuerstlein, Rachel und Harbeck, Nadia
(2016):
ABC3 Consensus: Assessment by a German Group of Experts.
In: Breast Care, Bd. 11, Nr. 1: S. 61-70
[PDF, 93kB]
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C.; Hanfstein, Benjamin; Krause, Stefan W.; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrmann, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger und Saußele, Susanne
(Juli 2014):
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
In: Annals of Hematology, Bd. 93, Nr. 7: S. 1167-1176
[PDF, 985kB]